Literature DB >> 24269834

Alternative carriers in dry powder inhaler formulations.

Yahya Rahimpour1, Maryam Kouhsoltani2, Hamed Hamishehkar3.   

Abstract

The aerosolization efficiency of a powder is highly dependent on carrier characteristics, such as particle size distribution, shape and surface properties. The main objective in the inhalation field is to achieve a high and reproducible pulmonary deposition. This can be provided by successful carrier selection and careful process optimization for carrier modification. Lactose is the most common and frequently used carrier in dry powder inhaler (DPI) formulations. But lactose shows some limitations in formulation with certain drugs and peptides that prohibit its usage as a carrier in DPI formulations. Here, we criticality review the most important alternative carriers to lactose with merits, demerits and applications in DPI formulations.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24269834     DOI: 10.1016/j.drudis.2013.11.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  10 in total

1.  A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.

Authors:  S Focaroli; P T Mah; J E Hastedt; I Gitlin; S Oscarson; J V Fahy; A M Healy
Journal:  Int J Pharm       Date:  2019-03-05       Impact factor: 5.875

2.  Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.

Authors:  Nivedita Shetty; Heejun Park; Dmitry Zemlyanov; Sharad Mangal; Sonal Bhujbal; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2018-04-18       Impact factor: 5.875

3.  Spray freeze drying to solidify Nanosuspension of Cefixime into inhalable microparticles.

Authors:  Dorrin Mohtadi Haghighi; Homa Faghihi; Majid Darabi; Maryam Saadat Mirmoeini; Alireza Vatanara
Journal:  Daru       Date:  2022-01-08       Impact factor: 4.088

4.  Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery.

Authors:  Kena Zhao; Tao Guo; Caifen Wang; Yong Zhou; Ting Xiong; Li Wu; Xue Li; Priyanka Mittal; Senlin Shi; Ruxandra Gref; Jiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2020-05-07       Impact factor: 11.413

5.  Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance.

Authors:  Chune Zhu; Jianting Chen; Shihui Yu; Chailu Que; Lynne S Taylor; Wen Tan; Chuanbin Wu; Qi Tony Zhou
Journal:  Mol Pharm       Date:  2020-07-24       Impact factor: 4.939

6.  Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers.

Authors:  Priya Muralidharan; Evan Mallory; Monica Malapit; Don Hayes; Heidi M Mansour
Journal:  Pharmaceutics       Date:  2014-06-20       Impact factor: 6.321

Review 7.  Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2018-01-14

8.  Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice.

Authors:  Kei Miwata; Hirokazu Okamoto; Taku Nakashima; Daisuke Ihara; Yasushi Horimasu; Takeshi Masuda; Shintaro Miyamoto; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Ayumi Shibata; Takaaki Ito; Tomoyuki Okuda; Noboru Hattori
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-17       Impact factor: 8.886

9.  Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.

Authors:  Carlos Molina; Waseem Kaialy; Qiao Chen; Daniel Commandeur; Ali Nokhodchi
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

10.  Investigation of potential substandard dry powder inhalers on EU and North African markets - evaluation of the delivered and fine particle doses.

Authors:  Yue Zhang; Philippe Hubert; Cédric Hubert
Journal:  J Drug Assess       Date:  2022-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.